Alliance Pharma PLC Directorate Change (6702G)
November 23 2015 - 11:00AM
UK Regulatory
TIDMAPH
RNS Number : 6702G
Alliance Pharma PLC
23 November 2015
For immediate release 23 November 2013
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Directorate Change
Alliance Pharma plc (AIM: APH), the specialty pharmaceutical
company, announces that Anthony Booley is to leave the Company to
pursue other business interests. Anthony has been with Alliance for
17 years and has served on the Company's Board since the flotation
in 2003. Peter Butterfield, who becomes Chief Commercial Officer,
will begin to assume Anthony's responsibilities with immediate
effect. Anthony will remain in his role until the handover is
completed, which is anticipated to be by 31 March 2016.
John Dawson, Alliance Pharma's Chief Executive, commented: "On
behalf of the Board, I would like to thank Anthony for his
commitment and hard work over the 17 years that he has been at
Alliance and for the significant contribution he has made to the
Company's development. We wish him every success in his future
ventures."
For further information:
Alliance Pharma
plc
John Dawson, Chief + 44 (0) 1249
Executive 466966
Numis Securities
Limited
Nominated Adviser: Michael Meade + 44 (0) 20
/ Freddie Barnfield 7260 1000
Corporate Broking: David
Poutney / James Black
Buchanan
Mark Court / Sophie Cowles + 44 (0) 20
/ Jane Glover 7466 5000
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to
established niche products and owns or licenses the rights to more
than 60 pharmaceutical products and continues to explore
opportunities to expand the range.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAKMMZMKFVGKZM
(END) Dow Jones Newswires
November 23, 2015 11:00 ET (16:00 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024